CAPLIPOINTPharmaceuticals
Caplin Point Laboratories Ltd — Quarterly Results & Earnings
₹1504.80
-3.75%
Profit Growth YoY18.08%Latest quarter
Sales Growth YoY10.54%Latest quarter
Sales CAGR 5Y17.55%5 year compound
Profit CAGR 5Y20.48%5 year compound
📋
Quarterly Performance
YoY Profit Growth+18.08%
✅ Strong growth
YoY Sales Growth+10.54%
✅ Strong growth
OPM 5Y Average
31.89%Operating profit margin
EPS Growth 5Y
20.36%Interest Coverage
1072.58Higher = safer debt servicing
ROE
22.66%ROCE
25.85%💡
Growth Analysis
Caplin Point Laboratories Ltd reported YoY profit growth of 18.08% and revenue growth of 10.54% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 17.55% and profits at 20.48% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Caplin Point Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.